Stable neuropsychological deficits in adult polyglucosan body disease. J Clin Neurosci
Neuropsychology Unit, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. Journal of Clinical Neuroscience
(Impact Factor: 1.38).
06/2007; 14(5):473-7. DOI: 10.1016/j.jocn.2006.03.001
We describe a 61-year-old woman who gradually developed deficits of balance, gait, and the ability to negotiate movement in space, together with an unusual pattern of cognitive deficits. A series of non-invasive investigations over three years including EEG, CT, MRI, PET and serial neuropsychological review had not provided a diagnosis. Significantly, the four neuropsychological assessments had revealed no progressive decline in cognition. Brain biopsy revealed an abundance of corpora amylacea, and a diagnosis of adult polyglucosan body disease (APBD) was made. This case contributes to the body of knowledge about the cognitive manifestations of this rare disease, and the stability of its functional impact over time.
Available from: M Carmen Garcia Carreira
Neurologia (Barcelona, Spain) 01/2009; 24(1):75-7. · 1.38 Impact Factor
Neurologia (Barcelona, Spain) 01/2009; 24(1):74-5. · 1.38 Impact Factor
Available from: Micha Wilhelmus
[Show abstract] [Hide abstract]
ABSTRACT: Corpora amylacea (CA) are both age and neurodegeneration-related spherical bodies, consisting of polymerized proteins, often thought to be involved in sequestration of hazardous products of cellular metabolism in brain. Although CA formation is associated with cellular stress, the process underlying their formation remains obscure. Transglutaminases (TGs) are stress associated enzymes that induce molecular cross-links, leading to polymerization of substrate proteins. TG expression and activity are elevated in Alzheimer's disease (AD) and Parkinson's disease (PD), and TG-catalyzed cross-links are present in their lesions. Considering the nature of CA, the aim of this study was to investigate the presence of TGs and TG cross-links in CA of healthy aging brain, AD and PD brain, using immunohistochemistry. We observed TG1 and TG cross-links in CA, together with typical cytoskeletal proteins. Furthermore, the presence of proteins associated with AD or PD pathogenesis was not altered in CA of disease brain compared to controls. We propose that TG1-catalyzed cross-linking and consequent polymerization of cytoskeletal and cytoskeleton-associated proteins may underlie CA formation.
Neurobiology of aging 06/2009; 32(5):845-56. DOI:10.1016/j.neurobiolaging.2009.04.019 · 5.01 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.